2006 to 2020 Saw Decrease in Death Following First Heart Attack
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
THURSDAY, Sept. 21, 2023 -- Death rates following a first heart attack decreased for those without diabetes or with type 2 diabetes (T2D), but not for those with type 1 diabetes (T1D), according to a study scheduled to be presented at the annual meeting of the European Association for the Study of Diabetes, held from Oct. 2 to 6 in Hamburg, Germany.
Linn Glynn, from the Karolinska Institutet in Stockholm, and colleagues compared trends in survival after a first myocardial infarction in people with and without diabetes. The analysis included 2,527 individuals with T1D, 48,321 individuals with T2D, and 243,170 individuals without diabetes with a first myocardial infarction identified through national health care registries (2006 to 2020).
The researchers found that during follow-up (up to 1,095 days), there was a significant decreased annual incidence trend for all-cause death in the control group (−1.9 percent) and individuals with T2D (−1.3 percent), but no such trend was seen in individuals with T1D (0 percent) in an adjusted analysis. There was a decrease in the annual incidence of cardiovascular death observed for the control (−2.0 percent), T2D (−1.6 percent), and T1D (−0.5 percent) groups. Findings were similar for major cardiovascular events in the control (−2.3 percent), T2D (−1.9 percent), and T1D (−0.6 percent) groups.
"During the last 15 years, the trend in death and major cardiovascular events in people without diabetes and with T2D having a first-time myocardial infarction has decreased significantly," the authors write. "In contrast, such a decreased trend was absent in people with T1D. This finding highlights the urgent need for understanding the cardiovascular risk in people with T1D."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
Intensive HTN Treatment Cuts Early T2D Diagnosis-Linked CVD Event Risk
MONDAY, April 29, 2024 -- More intensive hypertensive therapy significantly reduces the excess risk for cardiovascular disease (CVD) events associated with earlier hypertension...
GLP1 Receptor Agonists Do Not Up Risk for Complications After Emergency Surgery
THURSDAY, April 25, 2024 -- The risk for postoperative respiratory complications is similar among patients undergoing emergency surgery regardless of preoperative glucagon-like...
ACP: Recommendations Developed for Newer Type 2 Diabetes Medications
MONDAY, April 22, 2024 -- In a clinical guideline issued by the American College of Physicians (ACP) and published online April 19 in the Annals of Internal Medicine...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.